BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27355473)

  • 1. High tumor mast cell density is associated with longer survival of colon cancer patients.
    Mehdawi L; Osman J; Topi G; Sjölander A
    Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.
    Osman J; Savari S; Chandrashekar NK; Bellamkonda K; Douglas D; Sjölander A
    Oncotarget; 2017 May; 8(21):34773-34786. PubMed ID: 28410235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
    Ghatak S; Satapathy SR; Sjölander A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
    Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
    Fukushima H; Ohsawa M; Ikura Y; Naruko T; Sugama Y; Suekane T; Kitabayashi C; Inoue T; Hino M; Ueda M
    Histopathology; 2006 Nov; 49(5):498-505. PubMed ID: 17064296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
    Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
    Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
    Gulubova M; Vlaykova T
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
    Yodavudh S; Tangjitgamol S; Puangsa-art S
    J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell phenotype in benign and malignant tumors of the prostate.
    Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
    Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
    Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
    Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mucosal mast cells promotes inflammation-related colon cancer development through recruiting and modulating inflammatory CD11b(+)Gr1(+) cells.
    Xu L; Yi HG; Wu Z; Han W; Chen K; Zang M; Wang D; Zhao X; Wang H; Qu C
    Cancer Lett; 2015 Aug; 364(2):173-80. PubMed ID: 25986744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer.
    Tan SY; Fan Y; Luo HS; Shen ZX; Guo Y; Zhao LJ
    World J Gastroenterol; 2005 Feb; 11(8):1210-4. PubMed ID: 15754407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
    Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
    J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
    Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
    Glajcar A; Szpor J; Pacek A; Tyrak KE; Chan F; Streb J; Hodorowicz-Zaniewska D; Okoń K
    Virchows Arch; 2017 May; 470(5):505-515. PubMed ID: 28315938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.